Further, both in ovarian and ER−/HER2- breast cancer patients, a co-expression pattern for UBE2Q1 alongwith B4GALT3 was observed suggesting a functional interaction and potential pathological contribution of these two genes in the cancer subtypes. This evidence concerns the gene UBE2Q1 and breast carcinoma.